1 INTRODUCTION
1.1 OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.3 RESEARCH METHODOLOGY
1.3.1 SECONDARY DATA
1.3.2 PRIMARY DATA
1.3.3 MARKET SIZE ESTIMATION
1.3.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.4 STAKEHOLDERS
1.5 CURRENCY
1.6 RESEARCH ASSUMPTIONS
1.7 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 DROC MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 COST STRUCTURE ANALYSIS
3.6 VALUE CHAIN ANALYSIS
3.7 COVID-19 IMPACT ANALYSES
4 INDUSTRY TRENDS
4.1 INTRODUCTION
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES MODEL
4.3.1 DEGREE OF COMPETITION
4.3.2 BARGAINING POWER OF BUYERS
4.3.3 BARGAINING POWER OF SUPPLIERS
4.3.4 THREAT FROM SUBSTITUTES
4.3.5 THREAT FROM NEW ENTRANTS
5 CELL LINE DEVELOPMENT SERVICES TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2015-2019
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 PRIMARY CELL LINES
5.6 CONTINUOUS CELL LINES
5.7 HYBRIDOMAS
5.8 RECOMBINANT CELL LINES
6 CELL LINE DEVELOPMENT SERVICES MARKET PRODUCT TYPE ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET PRODUCT TYPE ANALYSIS, 2015-2019
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 REAGENTS AND MEDIA
6.5.1 SERUM
6.5.1.1 Fetal Bovine Serum
6.5.1.2 Adult Bovine Serum
6.5.1.3 Other Animal Serum
6.5.2 MEDIA
6.5.2.1 Minimum Essential Media
6.5.2.2 Reduced Serum Media
6.5.2.3 Serum-free Media
6.5.3 REAGENTS
6.5.3.1 Supplements and Growth Factors
6.5.3.2 Buffers and Chemicals
6.5.3.3 Cell Dissociation Reagents
6.5.3.4 Cryopreservative Reagents
6.5.3.5 Others
6.6 EQUIPMENT
6.6.1 BIOSAFETY CABINETS
6.6.2 CELL COUNTERS AND VIABILITY SYSTEMS
6.6.3 INCUBATORS
6.6.4 CENTRIFUGES
6.6.5 BIOREACTORS
6.6.6 STORAGE EQUIPMENT
6.6.6.1 Cell Culture Refrigerators and Freezers
6.6.6.2 Cell Culture Cryogenic Storage
6.6.7 AUTOMATED SYSTEMS
6.6.8 MICROSCOPES
6.6.9 FILTRATION SYSTEMS
6.6.10 OTHERS
6.7 ACCESSORIES AND CONSUMABLES
7 CELL LINE DEVELOPMENT SERVICES MARKET SOURCE ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET SOURCE ANALYSIS, 2015-2019
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 MAMMALIAN CELL LINE
7.5.1 INSECTS
7.5.2 AMPHIBIANS
7.6 NON-MAMMALIAN CELL LINE
8 CELL LINE DEVELOPMENT SERVICES MARKET APPLICATION ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 BIOPRODUCTION
8.5.1 DIAGNOSTICS
8.5.2 VACCINES
8.5.3 RECOMBINANT PROTEIN THERAPEUTICS
8.6 DRUG DISCOVERY
8.7 TOXICITY TESTING
8.8 TISSUE ENGINEERING & REGENERATIVE MEDICINES
8.9 TOXICITY TESTING
8.10 RESEARCH
8.11 OTHER APPLICATIONS
9 GLOBAL CELL LINE DEVELOPMENT SERVICES REGIONAL ANALYSIS
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
9.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
9.2.3 Y-O-Y GROWTH TREND ANALYSIS
9.2.3.1 U.S.
9.2.3.2 Canada
9.2.3.3 Mexico
9.3 ASIA-PACIFIC
9.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
9.3.2 Y-O-Y GROWTH TREND ANALYSIS
9.3.2.1 China
9.3.2.2 Japan
9.3.2.3 Korea
9.3.2.4 India
9.3.2.5 Southeast Asia
9.4 MIDDLE EAST AND AFRICA
9.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
9.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
9.4.3 Y-O-Y GROWTH TREND ANALYSIS
9.4.3.1 Saudi Arabia
9.4.3.2 UAE
9.4.3.3 Egypt
9.4.3.4 Nigeria
9.4.3.5 South Africa
9.5 EUROPE
9.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
9.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
9.5.3 Y-O-Y GROWTH TREND ANALYSIS
9.5.3.1 Germany
9.5.3.2 France
9.5.3.3 UK
9.5.3.4 Russia
9.5.3.5 Italy
9.6 SOUTH AMERICA
9.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2015-2019
9.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2020–2030
9.6.3 Y-O-Y GROWTH TREND ANALYSIS
9.6.3.1 Brazil
9.6.3.2 Argentina
9.6.3.3 Columbia
10 MARKET PLAYERS
10.1 GENERAL ELECTRIC (GE HEALTHCARE)
10.1.1 BUSINESS OVERVIEW:
10.1.2 PRODUCT PORTFOLIO
10.1.3 RECENT DEVELOPMENTS
10.1.4 SWOT ANALYSIS:
10.2 THERMO FISHER SCIENTIFIC INC.
10.3 FUJIFILM HOLDINGS CORP. (FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A., INC.)
10.4 MERCK KGAA (SIGMA-ALDRICH CORPORATION)
10.5 LONZA GROUP AG
10.6 JSR CORPORATION (SELEXIS SA)
10.7 SARTORIUS AG
10.8 WUXI APPTEC CO. LTD. (WUXI BIOLOGICS)
10.9 MABPLEX USA INC.
10.10 SOLENTIM LTD.
10.11 3P BIOPHARMACEUTICALS
10.12 A & G PHARMACEUTICAL INC ( PRECISION ANTIBODY)
10.13 ABSCI, LLC
10.14 AGC INC. (AGC BIOLOGICS)
10.15 ALBANY MOLECULAR RESEARCH INC.
10.16 ANTHEM BIOSCIENCES PRIVATE LIMITED.
10.17 APPLIED STEMCELL INC.
10.18 ATUM
10.19 BATAVIA BIOSCIENCES B.V.
10.20 BIOFACTURA, INC.
10.21 BIOLOGICS INTERNATIONAL CORP.
10.22 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
10.23 BPS BIOSCIENCE, INC.
10.24 CATALENT INC.
10.25 CELONIC AG (GLYCOTOPE GMBH)
10.26 CEVEC PHARMACEUTICALS GMBH
10.27 CHARLES RIVER LABORATORIES INTERNATIONAL INC.
10.28 COGNATE BIOSERVICES INC.
10.29 CREATIVE DIAGNOSTICS
10.30 CYTOVANCE BIOLOGICS
10.31 DYADIC INTERNATIONAL, INC.
10.32 EIRGENIX, INC.
10.33 EUROFINS SCIENTIFIC S.E
10.34 EVOTEC
10.35 FUSION ANTIBODIES
10.36 GENSCRIPT BIOTECH CORPORATION
10.37 GVK BIOSCIENCES PRIVATE LIMITED
10.38 HORIZON DISCOVERY LTD.
10.39 JHL BIOTECH INC.
10.40 KEMWELL BIOPHARMA
10.41 LAKE PHARMA INC.
10.42 LFB BIOMANUFACTURING
10.43 MINAPHARM PHARMACEUTICALS
10.44 NEUCLONE PTY. LTD.
10.45 PANGEN BIOTECH INC
10.46 POLPHARMA BIOLOGICS S.A
10.47 PRECISION ANTIBODY
10.48 PREMAS BIOTECH PVT LTD
10.49 PROVENTUS BIO
10.50 PX'THERAPEUTICS
10.51 RENTSCHLER BIOPHARMA SE
10.52 SAMSUNG BIOLOGICS CO. LTD.
10.53 SINO BIOLOGICAL INC.
10.54 SYD LABS
10.55 SYNGENE INTERNATIONAL LTD.
10.56 THE ANTIBODY LAB
10.57 TRENZYME GMBH
11 ABOUT US

TABLE 1 CELL LINE DEVELOPMENT SERVICES REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 2 GLOBAL CELL LINE DEVELOPMENT SERVICES MARKET, 2020–2030, (USD MILLION)
TABLE 3 CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE REGIONAL ANALYSIS, 2020–2030 (USD MILLION)
TABLE 4 GLOBAL CELL LINE DEVELOPMENT SERVICES HISTORICAL MARKET TYPE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 5 CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 6 GLOBAL CELL LINE DEVELOPMENT SERVICES HISTORICAL MARKET PRODUCT TYPE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 7 CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 8 GLOBAL CELL LINE DEVELOPMENT SERVICES HISTORICAL MARKET SOURCE ANALYSIS, 2015-2019, (USD MILLION)
TABLE 9 CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE SOURCE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 10 GLOBAL CELL LINE DEVELOPMENT SERVICES HISTORICAL MARKET APPLICATION ANALYSIS, 2015-2019, (USD MILLION)
TABLE 11 CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 12 NORTH AMERICA CELL LINE DEVELOPMENT SERVICES HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 13 NORTH AMERICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 14 NORTH AMERICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 15 NORTH AMERICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE SOURCE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 16 NORTH AMERICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 17 U.S. CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2015–2020
TABLE 18 U.S. CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 19 U.S. CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 20 CANADA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 21 CANADA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 22 MEXICO CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 23 MEXICO CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 24 APAC CELL LINE DEVELOPMENT SERVICES HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 25 ASIA-PACIFIC CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 26 ASIA-PACIFIC CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 27 ASIA-PACIFIC CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE SOURCE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 28 ASIA-PACIFIC CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 29 CHINA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 30 CHINA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 31 JAPAN CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 32 JAPAN CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 33 KOREA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 34 KOREA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 35 INDIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 36 INDIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 37 SOUTHEAST ASIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 38 SOUTHEAST ASIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA CELL LINE DEVELOPMENT SERVICES HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE SOURCE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 44 SAUDI ARABIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 45 SAUDI ARABIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 46 UAE CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 47 UAE CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 48 EGYPT CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 49 EGYPT CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 50 NIGERIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 51 NIGERIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 52 SOUTH AFRICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 53 SOUTH AFRICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 54 EUROPE CELL LINE DEVELOPMENT SERVICES HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 55 EUROPE CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 56 EUROPE CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 57 EUROPE CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE SOURCE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 58 EUROPE CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 59 GERMANY CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 60 GERMANY CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 61 FRANCE CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 62 FRANCE CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 63 UK CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 64 UK CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 65 RUSSIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 66 RUSSIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 67 ITALY CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 68 ITALY CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 69 SOUTH AMERICA CELL LINE DEVELOPMENT SERVICES HISTORICAL MARKET ANALYSIS, 2015-2019, (USD MILLION)
TABLE 70 SOUTH AMERICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 71 SOUTH AMERICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE PRODUCT TYPE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 72 SOUTH AMERICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE SOURCE ANALYSIS, 2020–2030 (USD MILLION)
TABLE 73 SOUTH AMERICA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030 (USD MILLION)
TABLE 74 BRAZIL CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 75 BRAZIL CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 76 ARGENTINA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 77 ARGENTINA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)
TABLE 78 COLUMBIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE TYPE ANALYSIS, 2020–2030, (USD MILLION)
TABLE 79 COLUMBIA CELL LINE DEVELOPMENT SERVICES CURRENT AND FUTURE APPLICATION ANALYSIS, 2020–2030, (USD MILLION)